Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations

P. D. Nallathamby, Karen Cowden Dahl, R. K. Roeder

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Contrast-enhanced computed tomography (CT) and spectral (color) X-ray CT have the potential to enable molecular imaging in CT and complement PET scans and MRI scans as a cheaper yet highly sensitive, high resolution, diagnostic tool. However, there is a lack of contrast agents designed to leverage the capabilities of spectral CT fully. In this talk, we will present a modular approach we have developed to create a spectral library of core-shell nanoparticle (NPs) contrast agents. The synthesis method will have broad applications in biomedical imaging due to potential for scalable synthesis of multi-modal imaging probes (e.g., fluorescence, MRI, X-ray, plasmonic resonance), dosed delivery of therapeutics and active targeting through molecular surface functionalization. Gold NPs (Au NPs), gadolinium oxide NPs (Gd203 NPs) and hafnium oxide NPs (Hf02 NPs) core compositions were prepared at a standard size (-10 nm) using solution phase synthesis. Controlled addition of silica shells (1-15 nm) enabled controlled loading of fluorescent molecules and provided a common platform for molecular surface functionalization. Antibodies and other small molecules were efficiently conjugated to the nanoparticles using appropriate CLICK chemistry. The bioactivity and orientation of antibodies conjugated to NPs were confirmed through agglomeration assays and electron microscopy. Quantitative assays reported a steady conjugation efficiency of 75%-80%. Bioconjugation allowed the multi-modal bioactive NPs were then successfully targeted in vitro and in vivo to metastasis-promoting cdl33(+) SKOV3-IP cells, which are responsible for poor prognosis in ovarian cancer patients. The in-vitro and in-vivo data can be discussed in detail with the corresponding author.

Original languageEnglish (US)
Title of host publicationBiotech, Biomaterials and Biomedical - TechConnect Briefs 2017
PublisherTechConnect
Pages122-125
Number of pages4
Volume3
ISBN (Electronic)9780998878201
StatePublished - Jan 1 2017
Event11th Annual TechConnect World Innovation Conference and Expo, Held Jointly with the 20th Annual Nanotech Conference and Expo, and the 2017 National SBIR/STTR Conference - Washington, United States
Duration: May 14 2017May 17 2017

Other

Other11th Annual TechConnect World Innovation Conference and Expo, Held Jointly with the 20th Annual Nanotech Conference and Expo, and the 2017 National SBIR/STTR Conference
CountryUnited States
CityWashington
Period5/14/175/17/17

Fingerprint

Nanoparticles
Tomography
Cells
Imaging techniques
Contrast Media
Antibodies
Population
Assays
Neoplasms
Molecular Imaging
X Ray Computed Tomography
Hafnium oxides
Molecular imaging
X rays
Silicon Dioxide
Gold
Positron-Emission Tomography
Ovarian Neoplasms
Libraries
Molecules

Keywords

  • Core-shell
  • Modular platform
  • Ovarian cancer
  • Spectral CT
  • X-ray CT

ASJC Scopus subject areas

  • Fuel Technology
  • Surfaces, Coatings and Films
  • Biotechnology
  • Fluid Flow and Transfer Processes

Cite this

Nallathamby, P. D., Cowden Dahl, K., & Roeder, R. K. (2017). Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations. In Biotech, Biomaterials and Biomedical - TechConnect Briefs 2017 (Vol. 3, pp. 122-125). TechConnect.

Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations. / Nallathamby, P. D.; Cowden Dahl, Karen; Roeder, R. K.

Biotech, Biomaterials and Biomedical - TechConnect Briefs 2017. Vol. 3 TechConnect, 2017. p. 122-125.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Nallathamby, PD, Cowden Dahl, K & Roeder, RK 2017, Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations. in Biotech, Biomaterials and Biomedical - TechConnect Briefs 2017. vol. 3, TechConnect, pp. 122-125, 11th Annual TechConnect World Innovation Conference and Expo, Held Jointly with the 20th Annual Nanotech Conference and Expo, and the 2017 National SBIR/STTR Conference, Washington, United States, 5/14/17.
Nallathamby PD, Cowden Dahl K, Roeder RK. Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations. In Biotech, Biomaterials and Biomedical - TechConnect Briefs 2017. Vol. 3. TechConnect. 2017. p. 122-125
Nallathamby, P. D. ; Cowden Dahl, Karen ; Roeder, R. K. / Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations. Biotech, Biomaterials and Biomedical - TechConnect Briefs 2017. Vol. 3 TechConnect, 2017. pp. 122-125
@inproceedings{b7a62e5c7a0b4e9a9448c22d6ecfad68,
title = "Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations",
abstract = "Contrast-enhanced computed tomography (CT) and spectral (color) X-ray CT have the potential to enable molecular imaging in CT and complement PET scans and MRI scans as a cheaper yet highly sensitive, high resolution, diagnostic tool. However, there is a lack of contrast agents designed to leverage the capabilities of spectral CT fully. In this talk, we will present a modular approach we have developed to create a spectral library of core-shell nanoparticle (NPs) contrast agents. The synthesis method will have broad applications in biomedical imaging due to potential for scalable synthesis of multi-modal imaging probes (e.g., fluorescence, MRI, X-ray, plasmonic resonance), dosed delivery of therapeutics and active targeting through molecular surface functionalization. Gold NPs (Au NPs), gadolinium oxide NPs (Gd203 NPs) and hafnium oxide NPs (Hf02 NPs) core compositions were prepared at a standard size (-10 nm) using solution phase synthesis. Controlled addition of silica shells (1-15 nm) enabled controlled loading of fluorescent molecules and provided a common platform for molecular surface functionalization. Antibodies and other small molecules were efficiently conjugated to the nanoparticles using appropriate CLICK chemistry. The bioactivity and orientation of antibodies conjugated to NPs were confirmed through agglomeration assays and electron microscopy. Quantitative assays reported a steady conjugation efficiency of 75{\%}-80{\%}. Bioconjugation allowed the multi-modal bioactive NPs were then successfully targeted in vitro and in vivo to metastasis-promoting cdl33(+) SKOV3-IP cells, which are responsible for poor prognosis in ovarian cancer patients. The in-vitro and in-vivo data can be discussed in detail with the corresponding author.",
keywords = "Core-shell, Modular platform, Ovarian cancer, Spectral CT, X-ray CT",
author = "Nallathamby, {P. D.} and {Cowden Dahl}, Karen and Roeder, {R. K.}",
year = "2017",
month = "1",
day = "1",
language = "English (US)",
volume = "3",
pages = "122--125",
booktitle = "Biotech, Biomaterials and Biomedical - TechConnect Briefs 2017",
publisher = "TechConnect",

}

TY - GEN

T1 - Modular nanoparticle probes for personalized in vitro and in vivo imaging of cancer cell populations

AU - Nallathamby, P. D.

AU - Cowden Dahl, Karen

AU - Roeder, R. K.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Contrast-enhanced computed tomography (CT) and spectral (color) X-ray CT have the potential to enable molecular imaging in CT and complement PET scans and MRI scans as a cheaper yet highly sensitive, high resolution, diagnostic tool. However, there is a lack of contrast agents designed to leverage the capabilities of spectral CT fully. In this talk, we will present a modular approach we have developed to create a spectral library of core-shell nanoparticle (NPs) contrast agents. The synthesis method will have broad applications in biomedical imaging due to potential for scalable synthesis of multi-modal imaging probes (e.g., fluorescence, MRI, X-ray, plasmonic resonance), dosed delivery of therapeutics and active targeting through molecular surface functionalization. Gold NPs (Au NPs), gadolinium oxide NPs (Gd203 NPs) and hafnium oxide NPs (Hf02 NPs) core compositions were prepared at a standard size (-10 nm) using solution phase synthesis. Controlled addition of silica shells (1-15 nm) enabled controlled loading of fluorescent molecules and provided a common platform for molecular surface functionalization. Antibodies and other small molecules were efficiently conjugated to the nanoparticles using appropriate CLICK chemistry. The bioactivity and orientation of antibodies conjugated to NPs were confirmed through agglomeration assays and electron microscopy. Quantitative assays reported a steady conjugation efficiency of 75%-80%. Bioconjugation allowed the multi-modal bioactive NPs were then successfully targeted in vitro and in vivo to metastasis-promoting cdl33(+) SKOV3-IP cells, which are responsible for poor prognosis in ovarian cancer patients. The in-vitro and in-vivo data can be discussed in detail with the corresponding author.

AB - Contrast-enhanced computed tomography (CT) and spectral (color) X-ray CT have the potential to enable molecular imaging in CT and complement PET scans and MRI scans as a cheaper yet highly sensitive, high resolution, diagnostic tool. However, there is a lack of contrast agents designed to leverage the capabilities of spectral CT fully. In this talk, we will present a modular approach we have developed to create a spectral library of core-shell nanoparticle (NPs) contrast agents. The synthesis method will have broad applications in biomedical imaging due to potential for scalable synthesis of multi-modal imaging probes (e.g., fluorescence, MRI, X-ray, plasmonic resonance), dosed delivery of therapeutics and active targeting through molecular surface functionalization. Gold NPs (Au NPs), gadolinium oxide NPs (Gd203 NPs) and hafnium oxide NPs (Hf02 NPs) core compositions were prepared at a standard size (-10 nm) using solution phase synthesis. Controlled addition of silica shells (1-15 nm) enabled controlled loading of fluorescent molecules and provided a common platform for molecular surface functionalization. Antibodies and other small molecules were efficiently conjugated to the nanoparticles using appropriate CLICK chemistry. The bioactivity and orientation of antibodies conjugated to NPs were confirmed through agglomeration assays and electron microscopy. Quantitative assays reported a steady conjugation efficiency of 75%-80%. Bioconjugation allowed the multi-modal bioactive NPs were then successfully targeted in vitro and in vivo to metastasis-promoting cdl33(+) SKOV3-IP cells, which are responsible for poor prognosis in ovarian cancer patients. The in-vitro and in-vivo data can be discussed in detail with the corresponding author.

KW - Core-shell

KW - Modular platform

KW - Ovarian cancer

KW - Spectral CT

KW - X-ray CT

UR - http://www.scopus.com/inward/record.url?scp=85029390471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029390471&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:85029390471

VL - 3

SP - 122

EP - 125

BT - Biotech, Biomaterials and Biomedical - TechConnect Briefs 2017

PB - TechConnect

ER -